Bevacizumab in colorectal cancer.
Publication
, Journal Article
Sonpavde, G
Published in: N Engl J Med
October 14, 2004
Duke Scholars
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
October 14, 2004
Volume
351
Issue
16
Start / End Page
1690 / 1691
Location
United States
Related Subject Headings
- Research Design
- Randomized Controlled Trials as Topic
- Neoplasm Metastasis
- Humans
- General & Internal Medicine
- Disease Progression
- Cross-Over Studies
- Colorectal Neoplasms
- Bevacizumab
- Antineoplastic Combined Chemotherapy Protocols
Citation
APA
Chicago
ICMJE
MLA
NLM
Sonpavde, G. (2004). Bevacizumab in colorectal cancer. N Engl J Med, 351(16), 1690–1691. https://doi.org/10.1056/NEJM200410143511622
Sonpavde, Guru. “Bevacizumab in colorectal cancer.” N Engl J Med 351, no. 16 (October 14, 2004): 1690–91. https://doi.org/10.1056/NEJM200410143511622.
Sonpavde G. Bevacizumab in colorectal cancer. N Engl J Med. 2004 Oct 14;351(16):1690–1.
Sonpavde, Guru. “Bevacizumab in colorectal cancer.” N Engl J Med, vol. 351, no. 16, Oct. 2004, pp. 1690–91. Pubmed, doi:10.1056/NEJM200410143511622.
Sonpavde G. Bevacizumab in colorectal cancer. N Engl J Med. 2004 Oct 14;351(16):1690–1691.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
October 14, 2004
Volume
351
Issue
16
Start / End Page
1690 / 1691
Location
United States
Related Subject Headings
- Research Design
- Randomized Controlled Trials as Topic
- Neoplasm Metastasis
- Humans
- General & Internal Medicine
- Disease Progression
- Cross-Over Studies
- Colorectal Neoplasms
- Bevacizumab
- Antineoplastic Combined Chemotherapy Protocols